Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurosci Lett. 2009 Mar 27;453(1):73-6. doi: 10.1016/j.neulet.2009.01.062. Epub 2009 Jan 29.

Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery.

Author information

1
Centre de recherche, Hôpital du Sacré-Coeur de Montréal, Département de pharmacologie, Université de Montréal, Montréal, Québec, Canada.

Abstract

The systemic administration of atorvastatin has been shown to be neuroprotective after spinal cord injury (SCI), by decreasing the inflammatory response at the lesion site and by reducing neuronal and oligodendrocyte apoptosis. The latter effect spares white matter at the injury site and improves locomotion. The aim of this study was to confirm the neuroprotective efficacy of atorvastatin as well as its early action in limiting apoptosis with its administration post-SCI. Female Sprague-Dawley rats received an intra peritoneal injection of: (1) statin/saline (5mg/kg) at 2h after the contusion injury; (2) physiological saline at 2h post-SCI; or (3) physiological saline without injury. Statin-treated rats showed significant (p<0.05) improvement in locomotion at week 4 post-SCI compared to vehicle-treated animals. Explaining this outcome, caspase-3 activity decreased by 50% (p<0.05), and the histological TUNEL method revealed a decrease of approximately 20% in apoptotic cells at the injury site (p<0.01) at 4h post-SCI in atorvastatin-treated rats in comparison to vehicle-treated controls. These data demonstrate that atorvastatin is effective after experimental spinal cord contusion injury in preventing early apoptosis at the injury site within 2h post-administration.

PMID:
19429019
DOI:
10.1016/j.neulet.2009.01.062
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center